tert-Butyl (5-amino-2-methylphenyl)carbamate, 95.0%, 1g

N-[(11bR)-2,6-Di-2-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide, 98%, 1g

(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide, 95.0%, 250mg

Fmoc-Val-Cit-PAB, 250mg

(R)-3-(1-aminoethyl)-5-(trifluoromethyl)aniline hydrochloride, 98%, 250mg

5-Hexen-1-ol>97.0%(GC)250mL

(6-Nitro-1,3-benzodioxol-5-yl)amine, 95.0%, 5g

Ethyl (1R,2R)-2-((tert-butoxycarbonyl)amino)cyclopentane-1-carboxylate, 98%, 5g

Methyl 4-chloro-3,3-difluorobutyrate, 97.0%, 5g

Pent-1-yn-1-ylbenzene, 97%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 10000 ml, 315 mm, 1 Piece

H-Sar-OEt.HCl, 97.00%, 100g

FMOC-ALA-ALDEHYDE, 97.0%, 1g